Mohammad H. Pourgholami

4.7k total citations · 1 hit paper
107 papers, 3.6k citations indexed

About

Mohammad H. Pourgholami is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mohammad H. Pourgholami has authored 107 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Mohammad H. Pourgholami's work include Estrogen and related hormone effects (12 papers), Neuroscience and Neuropharmacology Research (11 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Mohammad H. Pourgholami is often cited by papers focused on Estrogen and related hormone effects (12 papers), Neuroscience and Neuropharmacology Research (11 papers) and Intraperitoneal and Appendiceal Malignancies (10 papers). Mohammad H. Pourgholami collaborates with scholars based in Australia, Iran and United Kingdom. Mohammad H. Pourgholami's co-authors include David L. Morris, Parvin Ataie-Kachoie, Ahmed H. Mekkawy, Martina H. Stenzel, Samar Masoumi Moghaddam, Samina Badar, Javed Akhter, Lisa Wang, Yoseop Kim and Mohammad Sayyah and has published in prestigious journals such as PLoS ONE, Cancer Research and Macromolecules.

In The Last Decade

Mohammad H. Pourgholami

105 papers receiving 3.6k citations

Hit Papers

The role of VEGF in cance... 2023 2026 2024 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad H. Pourgholami Australia 37 1.3k 636 527 460 436 107 3.6k
Soon‐Sun Hong South Korea 35 1.8k 1.3× 652 1.0× 537 1.0× 365 0.8× 294 0.7× 120 3.6k
Kyung Hee Jung South Korea 35 1.5k 1.1× 584 0.9× 343 0.7× 282 0.6× 262 0.6× 125 3.5k
S. Asha Nair India 34 2.0k 1.5× 891 1.4× 592 1.1× 240 0.5× 332 0.8× 80 3.8k
Antonia Aránega Spain 28 1.2k 0.9× 550 0.9× 220 0.4× 404 0.9× 257 0.6× 137 2.9k
Joanna Kopecka Italy 38 1.9k 1.4× 1.0k 1.6× 935 1.8× 296 0.6× 447 1.0× 92 3.7k
Min You United States 39 2.6k 1.9× 675 1.1× 556 1.1× 336 0.7× 261 0.6× 98 5.0k
Chiara Dianzani Italy 42 2.0k 1.5× 434 0.7× 344 0.7× 278 0.6× 781 1.8× 124 4.8k
Silvia Zappavigna Italy 35 1.7k 1.3× 805 1.3× 856 1.6× 153 0.3× 295 0.7× 100 3.6k
Anant Narayan Bhatt India 23 1.1k 0.8× 612 1.0× 475 0.9× 176 0.4× 396 0.9× 67 2.7k
Elena Monti Italy 35 1.1k 0.8× 1.2k 1.8× 275 0.5× 538 1.2× 152 0.3× 119 3.5k

Countries citing papers authored by Mohammad H. Pourgholami

Since Specialization
Citations

This map shows the geographic impact of Mohammad H. Pourgholami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad H. Pourgholami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad H. Pourgholami more than expected).

Fields of papers citing papers by Mohammad H. Pourgholami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad H. Pourgholami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad H. Pourgholami. The network helps show where Mohammad H. Pourgholami may publish in the future.

Co-authorship network of co-authors of Mohammad H. Pourgholami

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad H. Pourgholami. A scholar is included among the top collaborators of Mohammad H. Pourgholami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad H. Pourgholami. Mohammad H. Pourgholami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pourgholami, Mohammad H., et al.. (2025). The mTOR pathway in Gliomas: From molecular insights to targeted therapies. Biomedicine & Pharmacotherapy. 189. 118237–118237. 4 indexed citations
2.
Pourgholami, Mohammad H., et al.. (2025). The interaction between ΔNp63α and TAp63α, mediated by miR-205-5p, inhibits the migration of lung adenocarcinoma cells. Scientific Reports. 15(1). 11501–11501.
4.
Pournajaf, Sanaz, et al.. (2024). Fingolimod Inhibits C6 Rat Glioma Proliferation and Migration, Induces Sub‐G1 Cell Cycle Arrest, Mitochondrial and Extrinsic Apoptosis In Vitro and Reduces Tumour Growth In Vivo. Clinical and Experimental Pharmacology and Physiology. 52(1). e70012–e70012. 2 indexed citations
5.
Dargahi, Leila, et al.. (2020). The role of ERα36 in cell type-specific functions of estrogen and cancer development. Pharmacological Research. 163. 105307–105307. 17 indexed citations
6.
Fakhri, Sajad, et al.. (2019). The effects of anticancer medicinal herbs on vascular endothelial growth factor based on pharmacological aspects: a review study. Nutrition and Cancer. 73(1). 1–15. 28 indexed citations
7.
Ataie-Kachoie, Parvin, Mohammad H. Pourgholami, Des R. Richardson, & David L. Morris. (2014). Gene of the month: Interleukin 6 (IL-6). Journal of Clinical Pathology. 67(11). 932–937. 113 indexed citations
8.
Ataie-Kachoie, Parvin, et al.. (2014). p70 Ribosomal protein S6 kinase ( Rps6kb1 ): an update. Journal of Clinical Pathology. 67(12). 1019–1025. 61 indexed citations
9.
Pourgholami, Mohammad H., et al.. (2014). Albendazole loaded albumin nanoparticles for ovarian cancer therapy. 6(4). 227–236. 19 indexed citations
10.
Ataie-Kachoie, Parvin, Mohammad H. Pourgholami, & David L. Morris. (2012). Inhibition of the IL-6 signaling pathway: A strategy to combat chronic inflammatory diseases and cancer. Cytokine & Growth Factor Reviews. 24(2). 163–173. 102 indexed citations
11.
Pourgholami, Mohammad H. & David L. Morris. (2008). Inhibitors of Vascular Endothelial Growth Factor in Cancer. Cardiovascular & Hematological Agents in Medicinal Chemistry. 6(4). 343–347. 34 indexed citations
12.
Pourgholami, Mohammad H., et al.. (2007). THE ROLE OF SONOGRAPHY IN DIAGNOSIS OF THE INTERNAL ABDOMINAL INJURIES DUE TO TRAUMA. Journal of Birjand University of Medical Sciences. 14(130). 43–48. 1 indexed citations
13.
Pourgholami, Mohammad H., et al.. (2006). SILENT STROKE IN PATIENTS WITH ACUTE THROMBOTIC STROKE. Bimonthly Journal of Hormozgan University of Medical Sciences. 10(3). 237–241. 2 indexed citations
14.
Pourgholami, Mohammad H., Ying Lu, & David L. Morris. (2006). Albendazole inhibits paclitaxel-resistant 1A9PTX22 ovarian cancer cells.. Cancer Research. 66. 1271–1271. 2 indexed citations
15.
Pourgholami, Mohammad H., et al.. (2001). Effects of chronic estradiol benzoate treatment on amygdala kindled seizures in male rats. Epilepsy Research. 46(1). 45–51. 9 indexed citations
16.
Finlay, I. G., et al.. (2001). Hepatic arterial and intravenous administration of 1,25-dihydroxyvitamin D 3 - evidence of a clinically significant hepatic first-pass effect. Cancer Chemotherapy and Pharmacology. 48(3). 209–214. 5 indexed citations
17.
Akhter, Javed, et al.. (2000). Hepatic intra-arterial injection of lipiodol-1,25-dihydroxyvitamin D3 for hepatocellular carcinoma in rats.. PubMed. 20(4). 2739–44. 3 indexed citations
18.
Pourgholami, Mohammad H., et al.. (2000). 1,25-dihydroxyvitamin D3 dissolved in lipiodol produces a sustained antiproliferative effect in the human hepatoblastoma cell line HepG2.. PubMed. 20(2A). 723–7. 6 indexed citations
19.
Pourgholami, Mohammad H., et al.. (1995). The Neuroleptic Thioridazine Exerts Weak Anticonvulsant Activity in Amygdala Kindled Rats. Pharmacy and Pharmacology Communications. 1(12). 577–580. 3 indexed citations
20.
Zarrindast, Mohammad‐Reza, et al.. (1993). BUPROPION-INDUCE D CLIMBING THROU GH D -1 AND D-2 DOPAMINE RECEPTOR ACTIVATION. The Medical Journal of The Islamic Republic of Iran. 6(4). 285–289. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026